Jakimovski, Dejan http://orcid.org/0000-0001-7114-4958
Zivadinov, Robert
Weinstock, Zachary
Fuchs, Tom A.
Bartnik, Alexander
Dwyer, Michael G.
Bergsland, Niels
Weinstock-Guttman, Bianca
Benedict, Ralph H. B.
Funding for this research was provided by:
Consortium of Multiple Sclerosis Centers
Article History
Received: 9 March 2023
Revised: 5 July 2023
Accepted: 14 August 2023
First Online: 27 August 2023
Declarations
:
: Zachary Weinstock, Niels Bergsland, and Alexander Bartnik have nothing to disclose. Dejan Jakimovski serves as Associate Editor of Clinical Neurology and Neurosurgery and compensated by Elsevier B.V. Tom Fuchs receives research support from the European Committee for Treatment and Research in Multiple Sclerosis and received consulting fees for Click Therapeutics. Robert Zivadinov has received personal compensation from Bristol Myers Squibb, EMD Serono, Sanofi, Janssen, 415 Capital, MAPI Pharma and Novartis for speaking and consultant fees. He received financial support for research activities from Sanofi, Novartis, Bristol Myers Squibb, Octave, Mapi Pharma, CorEvitas, Protembis and V-WAVE Medical. Michael G. Dwyer received personal compensation from Keystone Heart for speaking and consultant fees. He received financial support for research activities from Bristol Myers Squibb, Novartis and Keystone Heart. Bianca Weinstock-Guttman received honoraria as a speaker and/or as a consultant for Biogen Idec, Teva Pharmaceuticals, EMD Serono, Genzyme, Sanofi, Genentech, Novartis, Celgene/BMS, Janssen and Horizon Dr Weinstock-Guttman received research funds from Biogen Idec, EMD Serono, Genzyme, Genentech, Sanofi, Novartis. Ralph HB Benedict received honoraria, speaking, or consulting fees from BMS, EMD Serono, Roche, Novartis, and Roche has received research support from Biogen, BMS, Novartis, National Institutes of Health and National Multiple Sclerosis Society. He has received royalties from Psychological Assessment resources, Inc.
: The study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. The study was approved by the University at Buffalo Institutional Review Board (IRB) and the requirement for informed consent for these retrospective analyses was waived. All study participants signed written consent when they were enrolled in the CEG-MS study.